I agree that this site is using cookies. You can find further informations here.
X
Roudot-Thoraval, F.
294  results:
Search for persons X
?
1

PIN151 PATIENTS TREATED FOR HEPATITIS C: AN OBSERVATIONAL S..:

Pol, S. ; Rodriguez, I. ; Fouad, F....
Value in Health.  22 (2019)  - p. S663 , 2019
Link: https://doi.org/10.1016/..
 
?
2

PIN23 TREATING PATIENTS WITH DAAS ALLOWED TO SAVE 1 BILLION..:

Leleu, H. ; Rodriguez, I. ; Blachier, M....
Value in Health.  22 (2019)  - p. S643 , 2019
Link: https://doi.org/10.1016/..
 
?
3

Evaluation de l'acceptabilité du dépistage par TROD au sein..:

Duracinsky, M. ; Thonon, F. ; Rousset Torrente, O....
Médecine et Maladies Infectieuses.  49 (2019)  4 - p. S164 , 2019
Link: https://doi.org/10.1016/..
 
?
4

PIN96 EPIDEMIOLOGICAL AND ECONOMIC IMPACTS OF POTENTIAL HCV..:

Leleu, H. ; Volant, J. ; Hauvespre, A....
Value in Health.  22 (2019)  - p. S654-S655 , 2019
Link: https://doi.org/10.1016/..
 
?
5

4.10-P17A new strategy for screening for infectious disease..:

Duracinsky, M ; Thonon, F ; Lert, F...
European Journal of Public Health.  28 (2018)  suppl_1 - p. , 2018
Link: https://doi.org/10.1093/..
 
?
6

Identifying residual risk of hepatocellular carcinoma follo..:

Audureau, E. ; Bourcier, V. ; Layese, R....
Journal of Hepatology.  66 (2017)  1 - p. S21-S22 , 2017
Link: https://doi.org/10.1016/..
 
?
7

HIV/HCV-coinfected cirrhotic patients are no longer at high..:

Salmon, D. ; Nahon, P. ; Layese, R....
Journal of Hepatology.  66 (2017)  1 - p. S72-S73 , 2017
Link: https://doi.org/10.1016/..
 
?
8

Efficacy and safety of sofosbuvir and daclatasvir for 8 wee..:

Hezode, C. ; Leroy, V. ; Rosa, I....
Journal of Hepatology.  66 (2017)  1 - p. S299-S300 , 2017
Link: https://doi.org/10.1016/..
 
?
9

HCV eradication reduces the occurrence of major adverse car..:

Cacoub, P. ; Nahon, P. ; Layese, R....
Journal of Hepatology.  66 (2017)  1 - p. S20-S21 , 2017
Link: https://doi.org/10.1016/..
 
?
10

Value Of Treating All Liver Fibrosis Stages To Reach Elimin..:

Tanguy Melac, A ; Asselah, T ; Ethgen, O...
Value in Health.  20 (2017)  9 - p. A798 , 2017
Link: https://doi.org/10.1016/..
 
?
11

Effectiveness and cost-effectiveness of antiviral treatment..:

Willmington, C. ; Ganne-Carrié, N. ; Roudot-Thoraval, F....
Journal of Hepatology.  66 (2017)  1 - p. S414-S415 , 2017
Link: https://doi.org/10.1016/..
 
?
12

Effects 4.5 years after an interactive GP educational semin..:

Ferrat, E ; Le Breton, J ; Guéry, E...
Family Practice.  33 (2016)  2 - p. 192-199 , 2016
Link: https://doi.org/10.1093/..
 
?
13

HEP-13 - Facteurs de risque de maladie rénale chronique che..:

Divard, G. ; Layese, R. ; Isnard Bagnis, C....
Médecine et Maladies Infectieuses.  46 (2016)  4 - p. 54-55 , 2016
Link: https://doi.org/10.1016/..
 
?
14

Viral Suppression is Not a risk Factor for CKD in Viral Cir..:

Bagnis, C.I. ; Layese, R. ; Divard, G....
Journal of Hepatology.  64 (2016)  2 - p. S256 , 2016
Link: https://doi.org/10.1016/..
 
?
15

Cost-Effectiveness and Budget Impact of Interferon-Free Dir..:

Deuffic-Burban, S. ; Obach, D. ; Canva, V....
Journal of Hepatology.  64 (2016)  2 - p. S470-S471 , 2016
Link: https://doi.org/10.1016/..
 
1-15